Next Article in Journal
Developer and Partnership Differences in COVID-19 and Other Infections: Insights from DNA Vaccines
Previous Article in Journal
INEAS’s Cost-Effectiveness Analysis of Vemurafenib: Paving the Way for Value-Based Pricing in Tunisia
 
 
Review

Article Versions Notes

J. Mark. Access Health Policy 2024, 12(4), 306-316; https://doi.org/10.3390/jmahp12040024
Action Date Notes Link
article xml file uploaded 22 October 2024 15:47 CEST Original file -
article xml uploaded. 22 October 2024 15:47 CEST Update -
article pdf uploaded. 22 October 2024 15:47 CEST Version of Record -
article html file updated 22 October 2024 15:49 CEST Original file -
article xml file uploaded 22 October 2024 16:07 CEST Update -
article xml uploaded. 22 October 2024 16:07 CEST Update https://www.mdpi.com/2001-6689/12/4/24/xml
article pdf uploaded. 22 October 2024 16:07 CEST Updated version of record https://www.mdpi.com/2001-6689/12/4/24/pdf
article html file updated 22 October 2024 16:08 CEST Update https://www.mdpi.com/2001-6689/12/4/24/html
Back to TopTop